InsidersTradesSigma
Track the Encompass Health Corp share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, Encompass Health Corp has logged 440 public disclosures. Market capitalisation: €11.9bn. The latest transaction was filed on 1 September 2026 (Levée d'options). Among the most active insiders: COLTHARP DOUGLAS E. The full history is free.
440
Insider Decl.
n/a
Thresholds
€274,225
3 ops.
Buy Volume
€33m
19 ops.
Sell Volume
56Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 5,186 of 29,063 companies
68.1
score / 100
Value60
Quality76
FCF yld3.7%
Earn yld4.8%
EV/EBITDA10.4x
ROE25%
Gross mgn96%
Net mgn9.5%
Debt/EBITDA1.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 September 2026
Declarations440 total
4,858 shares@ US$35.06Encompass Health Common StockSEC:0000785161-26-000208:0
4,858 shares@ US$121.09Encompass Health Common StockSEC:0000785161-26-000208:1
5,211 shares@ US$120.93Encompass Health Common StockSEC:0000785161-26-000209:0
18,869 shares@ US$125.380.019% mcap13.7% of flowEncompass Health Common StockSEC:0000785161-26-000192:0
171,569 shares@ US$125.460.17% mcap53.1% of flowEncompass Health Common StockSEC:0000785161-26-000191:0
1,579 shares@ US$126.060.0016% mcap0.5% of flowEncompass Health Common StockSEC:0000785161-26-000191:1
8,906 shares@ US$125.950.0090% mcap17.9% of flowEncompass Health Common StockSEC:0000785161-26-000190:0
319 shares@ US$112.400.0003% mcap22.4% of flowEncompass Health Common StockSEC:0000785161-26-000180:1
248 shares@ US$112.430.0003% mcap33.8% of flowEncompass Health Common StockSEC:0000785161-26-000178:1
11 shares0Encompass Health Common StockSEC:0000785161-26-000178:0
19 shares0Encompass Health Common StockSEC:0000785161-26-000172:0
29 shares0Encompass Health Common StockSEC:0000785161-26-000176:0
85 shares0Encompass Health Common StockSEC:0000785161-26-000170:0
85 shares0Encompass Health Common StockSEC:0000785161-26-000168:0
29 shares0Encompass Health Common StockSEC:0000785161-26-000164:0
4 shares0Encompass Health Common StockSEC:0000785161-26-000166:0
40 shares0Encompass Health Common StockSEC:0000785161-26-000174:0
21 shares0Encompass Health Common StockSEC:0000785161-26-000180:0
85 shares0Encompass Health Common StockSEC:0000785161-26-000117:0
261 shares@ US$106.170.0002% mcap49.3% of flowEncompass Health Common StockSEC:0000785161-26-000123:1
334 shares@ US$106.480.0003% mcap23.2% of flowEncompass Health Common StockSEC:0000785161-26-000113:1
27 shares0Encompass Health Common StockSEC:0000785161-26-000125:0
9 shares0Encompass Health Common StockSEC:0000785161-26-000123:0
27 shares0Encompass Health Common StockSEC:0000785161-26-000109:0
39 shares0Encompass Health Common StockSEC:0000785161-26-000111:0
25 of 440 declarations
关于 Encompass Health Corp
Encompass Health Corp. (NYSE: EHC) 是美国领先的住院康复医院服务提供商，总部位于阿拉巴马州伯明翰。该公司成立于 1984 年，当时名为 HealthSouth，并于 2019 年完成品牌重塑，更名为 Encompass Health。如今，它运营着全国最大的住院康复医院网络，并被广泛定位为中风、骨科手术、神经系统疾病和其他复杂医疗事件康复患者的重症急性后期护理专家。 公司的核心业务是运营住院康复医院，并得到与急性护理医院和医疗系统建立的有意义的合资企业网络的支持。其临床模式结合了每天三小时、每周五天的治疗、频繁的医生监督、24/7 的护理以及多学科康复服务。这种综合服务旨在恢复功能并帮助患者更快、更安全地回家，这是与其他急性后期护理替代方案的重要区别。 从竞争角度来看，Encompass Health 受益于规模、专业的临床专业知识以及在转诊来源、付款人和患者中建立的良好声誉。在其 2024 年年度报告中，管理层强调美国对住院康复服务存在巨大的未满足需求，这得益于人口老龄化和许可康复床位的供应受限。该公司还强调了其广泛的运营范围，指出其 166 家医院中有 65 家以合资企业形式运营，这支持了市场准入和地方合作。这些因素巩固了其在医疗保健服务中一个利基但具有战略重要性的领域中的全国领导地位。 从地理上看，Encompass Health 在美国多个州拥有广泛的业务足迹。其主要公司办事处和总部位于阿拉巴马州伯明翰。该网络通过开设新医院和增加床位持续扩张，巩固了公司的增长战略。例如，在 2025 年，该公司宣布计划在北拉斯维加斯开设一家新的住院康复医院，随后在佛罗里达州圣彼得堡开设了一家新医院，这表明其持续投资于产能扩张。 最近的发展也值得关注。在 2026 年 2 月，Encompass Health 公布了强劲的 2025 年第四季度和全年业绩，收入增长，EBITDA 扩张，并在年内增加了额外产能。管理层还提供了 2026 年的指导，并重申了美国人口老龄化带来的长期需求顺风。对于投资者而言，Encompass Health 提供了防御性医疗保健概况、专业的市场利基以及对结构性人口增长主题的敞口，同时仍在美国纽约证券交易所上市。
